Inherited variations in human pigmentation-related genes modulate cutaneous melanoma risk and clinicopathological features in Brazilian population
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inherited variations in human pigmentation-related genes modulate cutaneous melanoma risk and clinicopathological features in Brazilian population
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-22
DOI
10.1038/s41598-020-68945-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8
- (2019) Haruhi Fukuhisa et al. JOURNAL OF HUMAN GENETICS
- MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma
- (2019) Edward Kim et al. CANCER RESEARCH
- Current state of melanoma diagnosis and treatment
- (2019) Lauren E. Davis et al. CANCER BIOLOGY & THERAPY
- CASP8 (rs3834129) and CASP3 (rs4647601) polymorphisms in oropharynx cancer risk, tumor cell differentiation, and prognosis in a cohort of the Brazilian population
- (2019) Gabriela Arielo Tortorelli et al. MOLECULAR BIOLOGY REPORTS
- Genome-wide association study in 176,678 Europeans reveals genetic loci for tanning response to sun exposure
- (2018) Alessia Visconti et al. Nature Communications
- Targeting lineage-specific MITF pathway in human melanoma cell lines by A-485, the selective small molecule inhibitor of p300/CBP
- (2018) Rui Wang et al. MOLECULAR CANCER THERAPEUTICS
- Kazinol U inhibits melanogenesis through the inhibition of tyrosinase-related proteins via AMPK activation
- (2018) Jihyun Lim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Integration of protein interaction and gene co-expression information for identification of melanoma candidate genes
- (2018) Kejia Wu et al. MELANOMA RESEARCH
- Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways
- (2018) David L. Duffy et al. Nature Communications
- Challenges and progress in interpretation of non-coding genetic variants associated with human disease
- (2017) Yizhou Zhu et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- IRF4rs12203592 functional variant and melanoma survival
- (2017) Miriam Potrony et al. INTERNATIONAL JOURNAL OF CANCER
- A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF
- (2017) Jiyeon Choi et al. NATURE GENETICS
- Knockdown of CREB1 inhibits tumor growth of human gastric cancer in vitro and in vivo
- (2017) Min Rao et al. ONCOLOGY REPORTS
- PDCD1 gene polymorphisms as regulators of T-lymphocyte activity in cutaneous melanoma risk and prognosis
- (2017) Gabriela V. B. Gomez et al. Pigment Cell & Melanoma Research
- Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma
- (2017) Katherine J. Ransohoff et al. Oncotarget
- Melanin content in melanoma metastases affects the outcome of radiotherapy
- (2016) Anna A. Brożyna et al. Oncotarget
- Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
- (2015) Matthew H Law et al. NATURE GENETICS
- Overexpression of adenylate cyclase-associated protein 2 is a novel prognostic marker in malignant melanoma
- (2015) Yohei Masugi et al. PATHOLOGY INTERNATIONAL
- Melanoma
- (2015) Dirk Schadendorf et al. Nature Reviews Disease Primers
- Upregulation of adenylate cyclase 3 (ADCY3) increases the tumorigenic potential of cells by activating the CREB pathway
- (2015) Seung-Hyun Hong et al. Oncotarget
- Cyclic AMP (cAMP) signaling in melanocytes and melanoma
- (2014) Carlos Iván Rodríguez et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The role of melanogenesis in regulation of melanoma behavior: Melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways
- (2014) A. Slominski et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Indications and Options for Systemic Therapy in Melanoma
- (2014) Vernon K. Sondak et al. SURGICAL CLINICS OF NORTH AMERICA
- An integrated approach to reduce the impact of minor allele frequency and linkage disequilibrium on variable importance measures for genome-wide data
- (2012) Raymond Walters et al. BIOINFORMATICS
- Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial
- (2012) Bryan H Burmeister et al. LANCET ONCOLOGY
- 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial
- (2011) Peter Gillgren et al. LANCET
- The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than Expected
- (2011) Sérgio D. J. Pena et al. PLoS One
- Transcriptional control of the melanoma malignant phenotype
- (2010) Vladislava O. Melnikova et al. CANCER BIOLOGY & THERAPY
- Spliceosome Structure and Function
- (2010) C. L. Will et al. Cold Spring Harbor Perspectives in Biology
- Quantifying uncertainty in genotype calls
- (2009) Benilton S. Carvalho et al. BIOINFORMATICS
- What are melanocytesreallydoing all day long…?
- (2009) P. M. Plonka et al. EXPERIMENTAL DERMATOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Splicing Finder: an online bioinformatics tool to predict splicing signals
- (2009) François-Olivier Desmet et al. NUCLEIC ACIDS RESEARCH
- Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy
- (2008) Anna A. Brożyna et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells
- (2008) Andrzej Slominski et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started